Antimicrobial resistance and microbiological gap analysis for central nervous system-assocaited bacterial pathogens

Jafar Ammoura1, Nouruldeen Alshamaa1, Amjad Elamin1

  • 1Pathological Sciences Department, Division of Microbiology, College of Medicine, Ajman University, Ajman, United Arab Emirates.

Abstract

Insights

Central nervous system (CNS) infections in Nigeria show high antimicrobial resistance (AMR) and diagnostic gaps. Targeted microbiology interventions are crucial for effective treatment and surveillance of bacterial meningitis.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Central nervous system (CNS) infections pose a significant health burden in the African meningitis belt.
  • Rising antimicrobial resistance (AMR) complicates treatment for CNS infections not covered by vaccines.
  • Nigeria faces challenges with AMR in CNS pathogens and diagnostic limitations.

Purpose of the Study:

  • To map pathogen-specific AMR profiles and diagnostic gaps in CNS bacterial pathogens in Nigeria.
  • To inform precise microbiology-based interventions for improved surveillance and empiric therapy.
  • To address the growing challenge of AMR in CNS infections.

Main Methods:

  • Retrospective analysis of three-year national AMR surveillance data for CNS bacterial pathogens.
  • Data extracted from 25 sentinel laboratories and analyzed per CLSI/GLASS standards.
  • AMR profiles and diagnostic gaps assessed using descriptive statistics and Chi-square tests.

Main Results:

  • High culture positivity rates observed in females and older adults.
  • Dominant isolates included *Staphylococcus aureus*, *Escherichia coli*, and *Klebsiella* species.
  • High AMR levels noted for *Streptococcus pneumoniae*, *Klebsiella* species, *E. coli*, and *P. aeruginosa*.
  • Significant diagnostic gaps identified across all CNS bacterial pathogens, scoring maximum clinical risk.

Conclusions:

  • Species-level identification gaps and high AMR necessitate targeted microbiological diagnostics.
  • Expanded cerebrospinal fluid testing and antimicrobial susceptibility testing (AST)-guided empiric therapy are crucial.
  • Interventions must be tailored for resource-limited settings to combat CNS infections effectively.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...